Live Chat

CFD:er är komplexa instrument som innebär hög risk att du förlorar pengar snabbt på grund av hävstången. 74,2% av icke-professionella investerares konton förlorar pengar när de handlar med CFD:er hos den här leverantören. Du bör överväga om du förstår hur CFD:er fungerar och om du har råd att ta den höga risken att förlora dina pengar.

Close

Affär JnJ JNJ

Sälj
 Köp

JnJ realtidsdiagram

5m 15m 30m 1h 4h 1d 1w

Instrumentfundament

Weekly Search
Weekly
Daily
Datum Stäng Förändring Förändring (%) Öppna Hög Låg

Senaste nyheter

The person silhouette with fluctuating red and green stock charts, symbolizes uncertainty.
Vanessa L 2025 Jan 16, 11:00

Why Is the Stock Market Going Down Today and Are Interest Rates Going Down?

Stocks Shares
A tanker carrying heating oil on a foggy morning, symbolizes the global energy trade.
Vanessa L 2025 Jan 16, 09:02

What Influences the Price of Heating Oil Per Gallon Today? Insights on Futures Contract Crude Oil

Oil Commodities
Frances Wang 2025 Jan 15, 16:00

Stock market today: Dow Jones Futures Climb as Market Surges Past Key Levels

Stocks
Frances Wang 2025 Jan 15, 16:00

Rigetti stock price: Shares of Rigetti Computing (NASDAQ: RGTI) climbed 7%

Stocks
Frances Wang 2025 Jan 15, 16:00

Bitcoin news today: Why Bitcoin is Surpassing Gold in the Digital Age?

Cryptocurrencies
US unemployment 
Tommy Yap 2025 Jan 15, 16:00

Morning Note: U.S. Unemployment and Retail Sales Data Drive Market Focus

Morning Note USD GBP
Christine Voong 2025 Jan 15, 10:45

GBP Rate Update: Exploring the GBP to USD Forecast for 2025

GBP USD Forex
Christine Voong 2025 Jan 15, 08:00

Elon Musk’s TikTok Acquisition Rumors | TikTok Viewers Insights | Markets.com

Stocks Tech Shares

Info

Spread

0.91

Spread (%)

0.6183 %

Hävstångseffekt

1:2

Köp till dagslåneränta

-0.0597 %

Sälj till dagslåneränta

-0.0292 %

Valuta

USD

Handelstider

Marknaden är öppen

Torsdag

14:31 - 20:59

Måndag

14:31-20:59

Tisdag

14:31-20:59

Onsdag

14:31-20:59

Fredag

14:31-20:59

Analys och statistik

Öppna

---

Föregående stängning

---

52 veckors högsta/lägsta

--- – ---

Marknadsvärde

349032677376

Utelöpande aktier

2407620096

Rapportdatum (nästa)

2001-06-13

Utd-procent

2025-03-04

Datum efter utdelning

2025-02-18

Förväntad framtida årlig utdelningsprocent

4.96

Förväntad framtida årlig direktavkastning

0.0342

Vinst per aktie

6.05

Läs mer om detta instrument

JnJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company has a collaboration agreement with Stand Up To Cancer for research testing a combination of teclistamab and daratumumab to treat a rare disease AL amyloidosis. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Läs mer om detta instrument

Tillgång
Sälj
Köp
Förändring (%)

Handla nu

Handla nu

Handla nu

Handla nu
Relaterade instrument
Trustpilot
Live Chat